立生医药（苏州）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Formoterol Fumarate Inhalation Solution
- Product Name
- 富马酸福莫特罗吸入溶液
- Approval Number
- 国药准字H20253128
- Approval Date
- Jan 14, 2025
NMPA
Compound Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用复方异丙托溴铵溶液
- Approval Number
- 国药准字H20244056
- Approval Date
- Jun 18, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20234174
- Approval Date
- Mar 6, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20234175
- Approval Date
- Mar 6, 2024
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20243310
- Approval Date
- Mar 5, 2024
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20243302
- Approval Date
- Mar 5, 2024
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20243303
- Approval Date
- Mar 5, 2024
NMPA
Clinical Trials
No trials found
News
No news found